Evidence map›Paper›PMID 31660991›Full record

Trial reportJournal of the International Society of Sports Nutrition2019

The effects of a caffeine-like supplement, TeaCrine®, on muscular strength, endurance and power performance in resistance-trained men.

Kyle R Cesareo, Justin R Mason, Patrick G Saracino, Margaret C Morrissey, Michael J Ormsbee

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International Society of Sports Nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Theacrine as a novel ergogenic aid: impact on canoe sprint performance.Journal of the International Society of Sports Nutrition · 2025
    Trial
  3. Trial
  4. Effects of Theacrine as a Pre-Workout Supplement.International journal of environmental research and public health · 2022
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Theacrine FromFrontiers in nutrition · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyle R CesareoDepartment of Nutrition, Food & Exercise Sciences, Institute of Sports Sciences & Medicine, Florida State University, 1104 Spirit Way, Tallahassee, FL, 32306, USA.
Justin R MasonDepartment of Nutrition, Food & Exercise Sciences, Institute of Sports Sciences & Medicine, Florida State University, 1104 Spirit Way, Tallahassee, FL, 32306, USA.
Patrick G SaracinoDepartment of Nutrition, Food & Exercise Sciences, Institute of Sports Sciences & Medicine, Florida State University, 1104 Spirit Way, Tallahassee, FL, 32306, USA.
Margaret C MorrisseyDepartment of Nutrition, Food & Exercise Sciences, Institute of Sports Sciences & Medicine, Florida State University, 1104 Spirit Way, Tallahassee, FL, 32306, USA.
Michael J OrmsbeeDepartment of Nutrition, Food & Exercise Sciences, Institute of Sports Sciences & Medicine, Florida State University, 1104 Spirit Way, Tallahassee, FL, 32306, USA. mormsbee@fsu.edu.ORCID http://orcid.org/0000-0002-1939-7656

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTeaCrine® is the synthetic version to naturally occurring theacrine (1, 3, 7, 9-tetramethyluric acid) found in the leaves of Camellia kucha tea plants. A few studies have examined the effects of TeaCrine® on cognitive perception, but no research exists examining its effects on resistance exercise performance. The purpose of this study was to determine the efficacy of TeaCrine®, a caffeine-like compound, on maximal muscular strength, endurance, and power performance in resistance-trained men.

methodsTwelve resistance-trained men participated in a randomized, double-blind, cross-over designed study. Each participant performed one-repetition maximum (1RM) bench press, 1RM squat, bench press repetitions to failure (RTF) at 70% 1RM, squat RTF at 70% 1RM, and 2-km rowing time trial 90 min after consumption of: (1) Caffeine 300 mg (CAFF300); (2) TeaCrine® 300 mg (TEA300); (3) TeaCrine® + Caffeine (COMBO; 150 mg/150 mg); (4) Placebo 300 mg (PLA). Power and velocity were measured using a TENDO Power Analyzer. Visual analogue scales for energy, focus, motivation to exercise, and fatigue were administered at baseline and 90 min post-treatment ingestion (pre-workout). Rating of perceived exertion was assessed after bench press RTF and squat RTF.

resultsThere were no differences between groups for 1RM, RTF, and power in the bench press and squat exercises. Only CAFF300 resulted in significant increases in perceived energy and motivation to exercise vs. TEA300 and PLA (Energy: + 9.8%, 95% confidence interval [3.3-16.4%], p < 0.01; + 15.3%, 95% CI [2.2-28.5%], p < 0.02; Motivation to exercise: + 8.9%, 95% CI [0.2-17.6%], p = 0.04, + 14.8%, 95% CI [4.7-24.8%], p < 0.01, respectively) and increased focus (+ 9.6%, 95% CI [2.1-17.1%], p = 0.01) vs. TEA300, but there were no significant differences between CAFF300 and COMBO (Energy + 3.9% [- 6.9-14.7%], Focus + 2.5% [- 6.3-11.3%], Motivation to exercise + 0.5% [- 11.6-12.6%]; p > 0.05).

conclusionNeither TEA300, CAFF300, COMBO, or PLA (when consumed 90 min pre-exercise) improved muscular strength, power, or endurance performance in resistance-trained men. Only CAFF300 improved measures of focus, energy, and motivation to exercise.

Indexed as

AdultCaffeineCross-Over StudiesDouble-Blind MethodHumansMaleMuscle, SkeletalMuscle StrengthPerformance-Enhancing SubstancesPhysical EnduranceResistance TrainingUric AcidYoung Adult1,3,7,9-tetramethyluric acidCaffeinePerformance-Enhancing SubstancesUric AcidBench pressCaffeineEnduranceErgogenicPowerSquatStrengthSupplementsTeaCrine®

Identifiers

PMID31660991
PMCPMC6816173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.